Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.

Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine.

Honda-Okubo Y, Rajapaksha H, Sajkov D, Gordon D, Cox MMJ, Petrovsky N.

Hum Vaccin Immunother. 2017 Jun 3;13(6):1-11. doi: 10.1080/21645515.2017.1279765. Epub 2017 Feb 14.

PMID:
28301280
2.

Seasonal Influenza A H1N1pdm09 Virus and Severe Outcomes: A Reason for Broader Vaccination in Non-Elderly, At-Risk People.

Minchole E, Figueredo AL, Omeñaca M, Panadero C, Royo L, Vengoechea JJ, Fandos S, de Pablo F, Bello S.

PLoS One. 2016 Nov 10;11(11):e0165711. doi: 10.1371/journal.pone.0165711. eCollection 2016.

3.

Combinations of Oseltamivir and T-705 Extend the Treatment Window for Highly Pathogenic Influenza A(H5N1) Virus Infection in Mice.

Marathe BM, Wong SS, Vogel P, Garcia-Alcalde F, Webster RG, Webby RJ, Najera I, Govorkova EA.

Sci Rep. 2016 May 25;6:26742. doi: 10.1038/srep26742.

4.

Comparison of age-specific hospitalization during pandemic and seasonal influenza periods from 2009 to 2012 in Taiwan: a nationwide population-based study.

Sheu SM, Tsai CF, Yang HY, Pai HW, Chen SC.

BMC Infect Dis. 2016 Feb 24;16:88. doi: 10.1186/s12879-016-1438-x.

5.
6.

Critical illness associated with 2013-2014 influenza A (H1N1): Postpandemic characteristics, presentation and outcomes.

Wiesen J, Joshi D, Guzman JA, Duggal A.

Indian J Crit Care Med. 2015 Nov;19(11):636-41. doi: 10.4103/0972-5229.169328.

7.

Prevalence, genetics, and transmissibility in ferrets of Eurasian avian-like H1N1 swine influenza viruses.

Yang H, Chen Y, Qiao C, He X, Zhou H, Sun Y, Yin H, Meng S, Liu L, Zhang Q, Kong H, Gu C, Li C, Bu Z, Kawaoka Y, Chen H.

Proc Natl Acad Sci U S A. 2016 Jan 12;113(2):392-7. doi: 10.1073/pnas.1522643113. Epub 2015 Dec 28.

8.

Risk factors associated with mortality in patients infected with influenza A/H1N1 in Mexico.

Mata-Marín LA, Mata-Marín JA, Vásquez-Mota VC, Arroyo-Anduiza CI, Gaytán-Martínez JE, Manjarrez-Téllez B, Ochoa-Carrera LA, Sandoval-Ramírez JL.

BMC Res Notes. 2015 Sep 11;8:432. doi: 10.1186/s13104-015-1349-8.

9.

Impact of School Cycles and Environmental Forcing on the Timing of Pandemic Influenza Activity in Mexican States, May-December 2009.

Tamerius J, Viboud C, Shaman J, Chowell G.

PLoS Comput Biol. 2015 Aug 20;11(8):e1004337. doi: 10.1371/journal.pcbi.1004337. eCollection 2015 Aug.

10.

Emerging Infections of CNS: Avian Influenza A Virus, Rift Valley Fever Virus and Human Parechovirus.

Wiley CA, Bhardwaj N, Ross TM, Bissel SJ.

Brain Pathol. 2015 Sep;25(5):634-50. doi: 10.1111/bpa.12281. Review.

11.

B Cells and Functional Antibody Responses to Combat Influenza.

Lofano G, Kumar A, Finco O, Del Giudice G, Bertholet S.

Front Immunol. 2015 Jun 30;6:336. doi: 10.3389/fimmu.2015.00336. eCollection 2015. Review.

12.

Low expression of activation marker CD69 and chemokine receptors CCR5 and CXCR3 on memory T cells after 2009 H1N1 influenza A antigen stimulation in vitro following H1N1 vaccination of HIV-infected individuals.

Chawansuntati K, Chotirosniramit N, Sugandhavesa P, Aurpibul L, Thetket S, Kosashunhanan N, Supindham T, Kaewthip O, Sroysuwan P, Sirisanthana T, Suparatpinyo K, Wipasa J.

Hum Vaccin Immunother. 2015;11(9):2253-65. doi: 10.1080/21645515.2015.1051275. Epub 2015 Jun 19.

13.

Age-related differences in the accuracy of web query-based predictions of influenza-like illness.

Domnich A, Panatto D, Signori A, Lai PL, Gasparini R, Amicizia D.

PLoS One. 2015 May 26;10(5):e0127754. doi: 10.1371/journal.pone.0127754. eCollection 2015.

14.

Adaptive Mutations That Occurred during Circulation in Humans of H1N1 Influenza Virus in the 2009 Pandemic Enhance Virulence in Mice.

Otte A, Sauter M, Daxer MA, McHardy AC, Klingel K, Gabriel G.

J Virol. 2015 Jul;89(14):7329-37. doi: 10.1128/JVI.00665-15. Epub 2015 May 6.

15.

Surveillance for seasonal influenza virus prevalence in hospitalized children with lower respiratory tract infection in Guangzhou, China during the post-pandemic era.

Guan WD, Gong XY, Mok CK, Chen TT, Wu SG, Pan SH, Cowling BJ, Yang ZF, Chen DH.

PLoS One. 2015 Apr 13;10(4):e0120983. doi: 10.1371/journal.pone.0120983. eCollection 2015.

16.

Risk factors for death from Influenza A(H1N1)pdm09, State of São Paulo, Brazil, 2009.

Ribeiro AF, Pellini AC, Kitagawa BY, Marques D, Madalosso G, de Cassia Nogueira Figueira G, Fred J, Albernaz RK, Carvalhanas TR, Zanetta DM.

PLoS One. 2015 Mar 16;10(3):e0118772. doi: 10.1371/journal.pone.0118772. eCollection 2015.

17.

Protection against multiple subtypes of influenza viruses by virus-like particle vaccines based on a hemagglutinin conserved epitope.

Chen S, Zheng D, Li C, Zhang W, Xu W, Liu X, Fang F, Chen Z.

Biomed Res Int. 2015;2015:901817. doi: 10.1155/2015/901817. Epub 2015 Feb 12.

18.

Accounting for behavioral responses during a flu epidemic using home television viewing.

Springborn M, Chowell G, MacLachlan M, Fenichel EP.

BMC Infect Dis. 2015 Jan 23;15:21. doi: 10.1186/s12879-014-0691-0. Erratum in: BMC Infect Dis. 2016;16:474.

19.

CD206+ cell number differentiates influenza A (H1N1)pdm09 from seasonal influenza A virus in fatal cases.

Rodriguez-Ramirez HG, Salinas-Carmona MC, Barboza-Quintana O, Melo-de la Garza A, Ceceñas-Falcon LA, Rangel-Martinez LM, Rosas-Taraco AG.

Mediators Inflamm. 2014;2014:921054. doi: 10.1155/2014/921054. Epub 2014 Nov 25.

20.

A note on statistical and biological communication: a case study of the 2009 H1N1 pandemic.

Recoskie J, Heffernan JM, Jankowski HK.

BMC Res Notes. 2014 Dec 20;7:939. doi: 10.1186/1756-0500-7-939.

Supplemental Content

Support Center